XT
KYMR icon

XTX Topco’s Kymera Therapeutics KYMR Stock Holding History

XTX Topco’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.05M Buy
+61,501
New +$5.28M 0.09% 232
2026
Q1 		– Sell
-24,143
Closed -$1.88M – 4108
2025
Q4 		$1.88M Buy
+24,143
New +$1.63M 0.05% 603
2024
Q4 		– Sell
-5,987
Closed -$283K – 2631
2024
Q3 		$283K Sell
5,987
-761
-11% -$33.6K 0.02% 1226
2024
Q2 		$201K Buy
+6,748
New +$234K 0.02% 1237
2024
Q1 		– Sell
-13,566
Closed -$345K – 2104
2023
Q4 		$345K Sell
13,566
-8,146
-38% -$146K 0.08% 511
2023
Q3 		$302K Buy
+21,712
New +$437K 0.05% 727

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

XTX Topco's KYMR Position: Q2 2026 in Review

XTX Topco opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 61,501 shares worth $7.05M. The stake represents 0.09% of the portfolio and ranks #232 among its holdings. This is a return to the name: XTX Topco previously reported a position in KYMR as recently as Q4 2025.

XTX Topco first reported a position in KYMR in Q3 2023 and has held it in 6 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • XTX Topco held 61,501 shares of Kymera Therapeutics worth $7.05M as of Q2 2026.
  • Kymera Therapeutics was a new XTX Topco position in Q2 2026.
  • Kymera Therapeutics made up 0.09% of XTX Topco's portfolio in Q2 2026, its #232 holding.
  • XTX Topco first reported a position in Kymera Therapeutics in Q3 2023 and has held it in 6 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.